clopidogrel has been researched along with Thromboembolism in 150 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (2.00) | 18.2507 |
2000's | 48 (32.00) | 29.6817 |
2010's | 75 (50.00) | 24.3611 |
2020's | 24 (16.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CC; Chen, CT; Chien, SC; Hsieh, PC; Liu, YT; Liu, ZH; Wang, AY; Wang, YC; Yeap, MC | 1 |
Kozieł-Siołkowska, M; Lip, GY; Shantsila, E | 1 |
Amarenco, P; Bereczki, D; Czlonkowska, A; Diener, HC; Donovan, M; Endres, M; Gailani, D; Hankey, GJ; Kahl, A; Kasner, SE; Li, D; Lutsep, HL; Molina, CA; Ntaios, G; Perera, V; Sharma, M; Shuaib, A; Toyoda, K; Tsivgoulis, G | 1 |
Barber, J; Bass, DI; Carroll, K; Cruz, MJ; Feroze, AH; Kelly, CM; Kim, LJ; Lee, C; Levitt, MR; Levy, S; McCray, D; Sen, RD; Vanent, KN; Williams, JR; Young, CC | 1 |
Cheung, KS; Guo, CG; Leung, WK; Li, YK; Liu, KSH | 1 |
Ge, T; Song, EJ; Tang, S; Wang, J; Zhou, W; Zhu, Z | 1 |
Chang, CH; Cho, JH; Choi, JH; Chung, J; Chung, SY; Hwang, G; Jang, DK; Kang, DH; Kim, BT; Kim, SR; Kim, ST; Kim, TG; Kim, YW; Ko, J; Koh, JS; Koo, HW; Kwon, HJ; Kwon, SC; Lee, CY; Lee, JY; Lee, SW; Park, H; Park, JC; Park, JH; Rhee, J; Shin, BG; Shin, HG; Sung, JH; Yoon, SM; You, SH | 1 |
Barreau, X; Berge, J; Cagnazzo, F; Collemiche, FL; Costalat, V; Dargazanli, C; Derraz, I; Ferreira, I; Gariel, F; Gascou, G; Lefevre, PH; Marnat, G; Papaxanthos, J; Radu, RA; Riquelme, C | 1 |
Agbani, EO; Eagles, ME; Eesa, M; Hill, MD; Mitha, AP; Muram, S; Panchendrabose, K; Riva-Cambrin, J; Salam, MSA | 1 |
An, Z; Luo, L; Wang, X; Wang, Y | 1 |
Berdibekov, BS; Bulaeva, NI; Golukhova, EZ; Kubova, MC; Ruzina, EV | 1 |
Akbari, A; Barry, JP; Gravenor, MB; Halcox, JP; Harris, DE; Jenkins, GH; Lacey, A; Obaid, DR; Smith, DA | 1 |
Aoki, K; Fujimura, S; Ishibashi, T; Kaku, S; Kan, I; Karagiozov, K; Kato, N; Kodama, T; Murayama, Y; Nishimura, K; Sakuta, K; Sasaki, Y; Yuki, I | 1 |
Abdel-Wahab, M; Arnold, M; Balan, P; Blanke, P; Dangas, GD; De Backer, O; Guimarães, AHC; Jeger, RV; Jilaihawi, H; Kim, WK; Kini, AS; Kofoed, KF; Leipsic, JA; Makkar, R; Mathiassen, ON; Mehran, R; Nørgaard, BL; Søndergaard, L; Terkelsen, CJ; Van Mieghem, N; Veien, KT; Windecker, S | 1 |
Baldus, S; Dangas, GD; De Backer, O; Gilard, M; Giustino, G; Guimarães, AHC; Gullestad, L; Herrmann, HC; Kini, A; Mack, M; Makkar, RR; Mehran, R; Möllmann, H; Moreno, R; Schäfer, U; Seeger, J; Søndergaard, L; Tchétché, D; Thomitzek, K; Tijssen, JGP; Valgimigli, M; van Amsterdam, RGM; Volkl, AA; von Lewinski, D; Vranckx, P; Welsh, RC; Wildgoose, P; Windecker, S; Wöhrle, J; Zazula, A | 1 |
Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Kimura, T; Lip, GYH; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
Brennan, MM; Corliss, BM; Fox, WC; Freedman, R; Harris, NS; Hoh, BL; Nerva, JD; Polifka, AJ; Smith, J | 1 |
Bell, H; Dexter, M; Pasalic, L; Steinfort, B | 1 |
Berry, NC; Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Mauri, L; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM | 1 |
Abraham, NS; Herrin, J; Inselman, J; Ngufor, C; Noseworthy, PA; Sangaralingham, LR; Shah, ND; Yang, EH; Yao, X | 1 |
Baek, JW; Heo, YJ; Jeong, HW; Jin, SC; Kim, HJ; Kim, JS; Kim, SB; Kim, SH; Kim, ST; Lee, H; Park, JH | 1 |
Byeon, JS; Choe, J; Hwang, SW; Kim, GU; Lee, S; Myung, SJ; Park, SH; Yang, DH; Yang, SK; Ye, BD | 1 |
Abe, K; Ikeda, Y; Kitagawa, K; Kitazono, T; Matsumoto, M; Minematsu, K; Nagao, T; Nagata, I; Nanto, S; Nishikawa, M; Ogawa, A; Shirai, T; Tanahashi, N; Toyoda, K; Uchiyama, S; Yamagami, H | 1 |
Ando, M; Chihara, H; Funakoshi, Y; Furuta, K; Hashikawa, T; Hashimoto, T; Hatano, T; Higashi, E; Ishihara, T; Ishii, A; Kamata, T; Kira, J; Kitazono, T; Koge, J; Kondo, D; Matsumoto, S; Matsuo, K; Matsushita, T; Murai, H; Nakahara, I; Ohta, T; Sadamasa, N; Sonoda, K; Takita, W; Tanaka, K; Tokunaga, K; Tsujimoto, A | 1 |
Ban, SP; Bang, JS; Jo, HJ; Kim, T; Kim, YD; Kwon, OK; Lee, SU; Oh, CW; Won, YD | 1 |
Cho, E; Choi, SK; Jun, CH; Kim, HS; Park, CH; Rew, JS | 1 |
Han, FS; He, H; Ke, BB; Li, X; Li, Y; Zeng, YJ | 1 |
Lim, GB | 1 |
Bliden, KP; Gurbel, PA; Tantry, US; Venkataraman, G | 1 |
Cook, AM; Fraser, JF; Grupke, S; Kim, KS | 1 |
Doan, G; Kaltenbach, T; Lin, D; McQuaid, K; Mou, S; Pham, C; Rouse, RV; Shergill, AK; Soetikno, RM; Somsouk, M | 1 |
An, SJ; Cho, WS; Cho, YD; Choi, HH; Han, MH; Kang, HS; Kim, JE; Lee, JJ; Mun, JH; Yoo, DH | 1 |
Adeeb, N; Alturki, A; Enriquez, A; Griessenauer, CJ; Gupta, R; Leadon, M; Moore, JM; Ogilvy, CS; Salem, M; Schmalz, P; Schneider, AM; Thomas, AJ | 1 |
Benit, E; Bertrand, PB; Habran, M; Kenis, K; Lecomte, J; Moonen, L; Stroobants, D | 1 |
Buckley, L; Del Buono, MG; Di Sciascio, G; Iorio, EL; Mangiacapra, F | 1 |
Accola, K; Armitage, J; Askew, J; Azar, H; Copeland, J; Douville, EC; Duncan, D; Ely, J; Fermin, L; Gerdisch, M; Graeve, A; Hagberg, R; Hughes, GC; Jamieson, WRE; Kapoor, D; Kong, B; Landvater, L; Levy, P; Martin, T; McGrath, M; Meyer, S; Nichols, D; Puskas, JD; Quinn, R; Rhenman, B; Trotter, T; Wait, M; Yanagawa, B; Ye, J | 1 |
Cho, WS; Cho, YD; Ha, EJ; Han, MH; Kang, HS; Kim, JE; Kim, KH; Lee, J | 1 |
Chaparro, E; Fedorova, E; Griffin, A; Hauck, EF; Holmes, C; Manson, RJ | 1 |
Anthopoulos, P; Chandrasekhar, J; Claessen, B; Colombo, A; Dangas, G; Deliargyris, EN; Hengstenberg, C; Hildick-Smith, D; Hink, HU; Kupatt, C; Lefèvre, T; Mehran, R; Nijenhuis, VJ; Sartori, S; Ten Berg, JM; Tron, C; Van Belle, E; Windecker, S | 1 |
Ahn, KT; Chae, SC; Cho, MC; Choi, SW; Choi, UL; Gwon, HC; Jeong, JO; Jeong, MH; Jin, SA; Kim, CJ; Kim, HS; Kim, JH; Kim, YJ; Lee, JH; Seong, IW; Seong, SW | 1 |
Bhatt, DL; Brueckmann, M; Cannon, CP; Hohnloser, SH; Kimura, T; Kreuzer, J; Lip, GYH; Mauri, L; Miede, C; Montalescot, G; Nordaby, M; Oldgren, J; Ozkor, M; Steg, PG; Ten Berg, JM; Vardas, P | 1 |
de Potter, T; Dujka, L; Jiresova, E; Lekesova, V; Neuzil, P; Reddy, VY; Rensing, B; Tromp, SC; van der Heyden, J | 1 |
Higashi, T; Inoue, R; Mitsutake, T; Morinaga, Y; Nii, K | 1 |
Benz, AP; Beresh, H; Conen, D; Connolly, SJ; Healey, JS; Masiero, S; McIntyre, WF; Wang, J; Wong, JA | 1 |
Stiefelhagen, P | 2 |
Bazargan, A; Douglas, G; McKenzie, JL | 1 |
Albalbissi, K; Coffey, B; Khosla, S; Molnar, J; Panchal, HB; Patel, P; Ramu, V; Shah, T | 1 |
Darvish-Kazem, S; Douketis, JD; Gandhi, M; Marcucci, M | 1 |
Post, S; Wilhelm, TJ | 1 |
Dandamudi, V; Heller, RS; Lanfranchi, M; Malek, AM | 1 |
Byun, H; Cha, J; Hong, S; Jeon, P; Jo, K; Kim, B; Kim, H; Kim, K; Kim, S | 1 |
Diener, HC; Frank, B; Hajjar, K; Weimar, C | 1 |
Connolly, SJ; Hart, RG; Healey, JS; Hohnloser, SH; McAlister, FA; Pfeffer, MA; Sandhu, RK; Yuan, F; Yusuf, S | 1 |
Balalis, K; Elalamy, I; Gerotziafas, GT; Gionis, MN; Ioannou, CV; Kontopodis, N | 1 |
Angoulvant, D; Bejan-Angoulvant, T; Fauchier, L; Ivanes, F; Lip, GYH; Saint Etienne, C; Villejoubert, O | 1 |
Fletcher, J; Gruen, R; Koh, TL; Ong, WL; Royce, P | 1 |
Bruder, M; El-Fiki, A; Güresir, E; Konczalla, J; Lescher, S; Schuss, P; Seifert, V; Vatter, H | 1 |
Alaraj, A; Aletich, V; Tesoro, E; Wong, P | 1 |
Jiang, Y; Li, Y; Yang, H | 1 |
Assali, A; Codner, P; Eisen, A; Kornowski, R; Lev, EI; Orvin, K; Perl, L; Vaknin-Assa, H; Zemer-Wassercug, N | 1 |
Fox, PR; Hogan, DF; Jacob, K; Keene, B; Laste, NJ; Rosenthal, S; Sederquist, K; Weng, HY | 1 |
Agostoni, P; Baan, J; Bennaghmouch, N; Collet, JP; den Heijer, P; Deneer, VH; Hassell, M; Huber, K; Kelder, JC; Kievit, PC; Latib, A; Maisano, F; Nijenhuis, VJ; Onorati, F; Stella, PR; Ten Berg, JM; van 't Hof, A; van den Heuvel, AF; van der Harst, P; van der Kley, F; van Kuijk, JP; Veenstra, L | 1 |
Ban, SP; Bang, JS; Chinh, ND; Hwang, G; Kim, CH; Kim, T; Kwon, OK; Oh, CW; Tjahjadi, M | 1 |
Baber, U; Clemmensen, P; Dangas, GD; Feit, F; Gersh, BJ; Guagliumi, G; Mehran, R; Ohman, EM; Pocock, SJ; Schoos, MM; Stone, GW; Witzenbichler, B; Yu, J | 1 |
Garcia-Rinaldi, RF; Macdonald, RJ; McKellar, SH; Schaff, HV; Sundt, TM; Thompson, JL | 1 |
Giugliano, RP; Thomas, D | 1 |
Bédard, C; Dunn, M; Hamel-Jolette, A | 1 |
Alfonso, F; Angel, J; Bueno, H; Fernández-Avilés, F; Ferreira-González, I; García-Dorado, D; López-Minguez, JR; Mainar, V; Maristany, J; Prendergast, B; Rodríguez, O; Sambola, A; San Román, A; Tornos, P; Zueco, J | 1 |
Fischer, A; Hopt, UT; Marjanovic, G; Olschewski, M; Richter, S; Ruthmann, O; Schrag, HJ; Seitz, A | 1 |
Dedaj, R; Levy, W | 1 |
Carro-Pagán, C; García-Rinaldi, R; McKellar, SH; Quiñones, J; Rodríguez-Acosta, JF; Schaff, HV; Thompson, JL | 1 |
Breet, N; Dewilde, W; Ten Berg, J | 2 |
Gao, F; Jia, de A; Liu, XL; Nie, B; Shen, H; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhou, YJ | 1 |
Doraiswamy, VA | 1 |
García-Bracamonte, B; Vanaclocha, F | 1 |
Cayla, G; Cuisset, T | 1 |
Alkhatib, AA; Elkhatib, FA; Khatib, OF | 1 |
Dennis, MJ; London, NJ; McCarthy, MJ; Nasim, A; Naylor, AR; Sayers, RD; Sharpe, RY | 1 |
Cairns, JA; Eikelboom, JW; Hirsh, J; Paikin, JS | 1 |
Drexler, H; Fischer, D; Haentjes, J; Klein, G; Meyer, GP; Schaefer, A; Schieffer, B | 1 |
Gendlin, GE; Storozhakov, GI; Tronina, OA | 1 |
Lane, DA; Lip, GYH; Tapp, LD | 1 |
Li, SH; Wang, ZH; Zhang, W; Zhang, Y; Zhao, HJ; Zheng, ZT; Zhong, M | 1 |
Barequet, IS; Budnik, I; Moisseiev, J; Priel, A; Sachs, D; Salomon, O; Shenkman, B; Wasserzug, Y | 1 |
Bauer, T; Bouman, HJ; Ford, NF; Taubert, D; ten Berg, JM; van Werkum, JW | 1 |
Casas, JP; Hingorani, AD; Holmes, MV | 1 |
Clem, JR | 1 |
Douketis, JD | 1 |
Dwivedi, G; Felmeden, DC; Lip, GY | 1 |
Edry, R; Katz, Y | 1 |
Kondo, R; Matsumori, Y; Matsumoto, Y; Shimizu, H; Takahashi, A; Tominaga, T | 1 |
Afanas'eva, EV; Belousov, DIu; Belousov, IuB; Iavelov, IS; Mareev, VIu | 1 |
Grohmann, J; Hanke, CA; Nakamura, L; Stiller, B; Zieger, B | 1 |
Asai, T; Haraguchi, K; Izumi, T; Matsubara, N; Miyachi, S; Naito, T; Wakabayashi, T; Yamanouchi, T | 1 |
Johansson, PI; Kofoed, K; Lilleør, NB; Rafiq, S; Steinbrüchel, DA; Stissing, T; Zacho, M | 1 |
Lacasa, RC; Linares Vicente, JA; Pérez, JO | 1 |
de Caterina, R; Renda, G | 1 |
Connolly, SJ; Coppens, M; Dorian, P; Eikelboom, JW; Hart, RG; Lip, GY; Shestakovska, O; Yusuf, S | 1 |
Smith, SA | 1 |
Bennet, H; Berenstein, A; Brockington, C; Chong, J; Ewing, SL; Fifi, JT; Leesch, W; Narang, J | 1 |
Comin, J; Kallmes, DF | 1 |
Kanorsky, SG; Shevelev, VI | 1 |
Badr Eslam, R; Kaider, A; Lang, IM; Panzer, S | 1 |
Turpie, AG | 1 |
Banning, AP; Clarke, NR; Timperley, J | 1 |
Allgaier, C; Beer, J; Wunderlich, H | 1 |
Heemskerk, JW; Heijnen, VV; oude Egbrink, MG; Reneman, RS; Slaaf, DW; van Gestel, MA | 1 |
Meyer, BJ | 1 |
Dahm, M; Ehrlich, A; Eimermacher, A; Peetz, D; Rupprecht, HJ; Schlitt, A; von Bardeleben, RS | 1 |
Mousa, SA | 1 |
Schieber, M; Sechtem, U | 1 |
Hogan, DF; Ward, MP | 1 |
Cocci, F; De Caterina, R; Lazzerini, G; Lorenzoni, R | 1 |
Felmeden, DC; Lip, GY | 1 |
Coller, B; FitzGerald, GA; Hirsh, J; Patrono, C; Roth, G | 1 |
Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R | 1 |
Nicholls, C; Sani, M | 1 |
Galileeva, AN; Gritsenko, VV; Kadinskaia, MI; Mochalov, OIu; Orlovskiĭ, PI; Petrishina, TI; Polezhaev, DA; Vavilova, TV | 1 |
Bereznicki, LR; Jackson, SL; Peterson, GM | 1 |
Fehér, J; Nagy, V | 1 |
Alberti, PF; Del Soldato, P; Gresele, P; Minuz, P; Momi, S; Pitchford, SC | 1 |
Eikelboom, JW; Hankey, GJ | 1 |
Brosteanu, O; Busch, I; Niebauer, J; Schuler, G; Sick, PB; Thiele, H; Ulrich, M | 1 |
Arab, D; Cho, L; Joyal, D; Lewis, B; Leya, F; Steen, L | 1 |
García-Rinaldi, R | 1 |
Steinbeck, G | 1 |
Verheugt, FW | 1 |
Faxon, DP; Nesto, RW | 1 |
Hetzer, R; Potapov, EV | 1 |
Alkonyi, B; Feher, G; Kesmarky, G; Keszthelyi, Z; Koltai, K; Papp, E; Toth, K | 1 |
Bhatt, DL | 1 |
Graf, I; Kastrati, A; Pogatsa-Murray, G; Schömig, A; Sibbing, D; von Beckerath, N; Wieczorek, A | 1 |
Bavry, AA; Bhatt, DL; Ellis, SG; Rabbat, MG | 1 |
Jamieson, DG | 1 |
Meinertz, T | 1 |
Bochsen, L; Nielsen, AB; Steinbrüchel, DA | 1 |
Husted, SE; Overgaard, K; Poulsen, TS | 1 |
Connolly, SJ; Healey, JS; Hohnloser, SH; Pajitnev, D; Pfeffer, MA; Pogue, J; Yusuf, S | 1 |
Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z | 1 |
Delate, T; Johnson, SG; Rogers, K; Witt, DM | 1 |
Batchelor, WB; Buchbinder, M; Dubois, CL; Fitzgerald, PJ; Gammon, R; Garg, J; Hasselblad, V; Hermiller, JB; Kereiakes, DJ; Krucoff, MW; Lansky, AJ; Mehran, R; O'Shaughnessy, CD; Petersen, JL; Schofer, J; Simonton, CA; Turco, MA; Verheye, S; Wijns, W | 1 |
Bakhru, MR; Bhatt, DL | 1 |
Schneider, D | 1 |
Clagett, GP; Jackson, MR | 1 |
Ikeda, Y | 1 |
Calverley, DC | 1 |
Cerbone, AM; Di Minno, G; Tufano, A | 1 |
33 review(s) available for clopidogrel and Thromboembolism
Article | Year |
---|---|
Antiplatelet agents and anticoagulants for hypertension.
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin | 2022 |
Effect of Platelet Function Testing Guidance on Clinical Outcomes for Patients with Intracranial Aneurysms Undergoing Endovascular Treatment.
Topics: Clopidogrel; Embolization, Therapeutic; Endovascular Procedures; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thromboembolism; Treatment Outcome | 2023 |
Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Cardiac Resynchronization Therapy Devices; Cause of Death; Clopidogrel; Defibrillators, Implantable; Evidence-Based Medicine; Female; Humans; Injections, Subcutaneous; Male; Network Meta-Analysis; Observational Studies as Topic; Pacemaker, Artificial; Perioperative Care; Prognosis; Risk Assessment; Survival Analysis; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Antithrombotic therapy: Dual therapy after PCI in AF.
Topics: Antithrombins; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Thromboembolism | 2017 |
Perioperative management of anticoagulation in elective surgery.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Diseases; Clopidogrel; Dabigatran; Elective Surgical Procedures; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Thromboembolism; Ticlopidine; Withholding Treatment | 2013 |
Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.
Topics: Aspirin; Blood Platelets; Cilostazol; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Thromboembolism; Ticlopidine | 2013 |
Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines.
Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Elective Surgical Procedures; Hemorrhage; Humans; Metals; Perioperative Care; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Thromboembolism; Ticlopidine; Time Factors; Withholding Treatment | 2013 |
[The most important aspects of risk assessment].
Topics: Algorithms; Aspirin; Cardiovascular Diseases; Clopidogrel; Digestive System Surgical Procedures; Drug Substitution; Drug Therapy, Combination; Health Status Indicators; Hemorrhage; Heparin; Humans; Perioperative Period; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Thromboembolism; Ticlopidine; Viscera | 2013 |
Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Severity of Illness Index; Survival Analysis; Thiophenes; Thromboembolism; Ticlopidine; Treatment Outcome | 2009 |
Aspirin and clopidogrel resistance: should we worry about?
Topics: Aspirin; Clopidogrel; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine | 2010 |
New antithrombotic agents--insights from clinical trials.
Topics: Adenosine; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine | 2010 |
[Antithrombotic therapy in patients with prosthetic heart valves].
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Drug Monitoring; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Prognosis; Thromboembolism; Ticlopidine; Warfarin | 2010 |
"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.
Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.
Topics: Acute Coronary Syndrome; Angina Pectoris; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Humans; Male; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Assessment; Selection Bias; Thromboembolism; Ticlopidine; Treatment Outcome | 2011 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Impact of antiplatelet therapy in heart disease.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Heart Diseases; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Treatment Outcome | 2012 |
Antithrombotic therapy.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation Disorders; Cat Diseases; Cats; Clopidogrel; Dog Diseases; Dogs; Heparin; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 2012 |
State of the art--a journey through the world of antithrombotic therapy.
Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Heart Failure; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Orthopedic Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Recurrence; Respiratory Insufficiency; Thromboembolism; Thrombolytic Therapy; Thrombophlebitis; Thrombosis; Ticlopidine | 2002 |
[Clopidogrel. Actions, pharmacokinetics, clinical studies].
Topics: Blood Platelets; Clopidogrel; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Thromboembolism; Thrombosis; Ticlopidine | 2002 |
Highlights of latest advances in antithrombotics.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Clopidogrel; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboembolism; Ticlopidine | 2004 |
Antiplatelet agents and anticoagulants for hypertension.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Humans; Hypertension; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2004 |
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Medicine; Extremities; Fibrinolytic Agents; Heparin; Humans; Intermittent Claudication; Ischemia; Randomized Controlled Trials as Topic; Risk Assessment; Tetrazoles; Thromboembolism; Ticlopidine; Vitamin K | 2004 |
[Clopidogrel in the prevention of stroke].
Topics: Clinical Trials as Topic; Clopidogrel; Humans; Injections, Intravenous; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Thromboembolism; Ticlopidine; Treatment Outcome | 2004 |
Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Assessment; Secondary Prevention; Stroke; Thromboembolism; Ticlopidine | 2005 |
Antiplatelet therapy in anticoagulated patients requiring coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stents; Thromboembolism; Ticlopidine; Warfarin | 2005 |
Antiplatelet therapy in populations at high risk of atherothrombosis.
Topics: Arteriosclerosis; Aspirin; Chemoprevention; Clopidogrel; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine | 2006 |
Identification of and management approaches for the high-risk patient.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine | 2006 |
Understanding and minimizing late thrombosis of drug-eluting stents.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Drug Delivery Systems; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stents; Thromboembolism; Ticlopidine; Time Factors | 2007 |
Interpreting the CHARISMA study. What is the role of dual antiplatelet therapy with clopidogrel and aspirin?
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine | 2008 |
Antithrombotic therapy in peripheral arterial occlusive disease.
Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Endarterectomy, Carotid; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Leg; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 1998 |
[Antiplatelet therapy].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Collagen; Humans; Immunoglobulin Fab Fragments; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboembolism; Thrombophilia; Ticlopidine | 1999 |
Antiplatelet therapy in the elderly. Aspirin, ticlopidine-clopidogrel, and GPIIb/GPIIIa antagonists.
Topics: Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Clopidogrel; Female; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Sensitivity and Specificity; Thromboembolism; Ticlopidine; Treatment Outcome | 2001 |
The use of antithrombotic drugs in older people.
Topics: Aged; Aspirin; Clopidogrel; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pulmonary Embolism; Secondary Prevention; Stroke; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin | 2002 |
25 trial(s) available for clopidogrel and Thromboembolism
Article | Year |
---|---|
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.
Topics: Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Factor XIa; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Thromboembolism; Treatment Outcome | 2022 |
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.
Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Four-Dimensional Computed Tomography; Heart Valve Prosthesis; Hemorrhage; Humans; Intention to Treat Analysis; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Thromboembolism; Transcatheter Aortic Valve Replacement | 2020 |
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Thromboembolism; Transcatheter Aortic Valve Replacement | 2020 |
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Dual Anti-Platelet Therapy; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Stents; Thromboembolism; Ticagrelor; Time Factors; Treatment Outcome; Warfarin | 2020 |
Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.
Topics: Aged; Blood Pressure; Clopidogrel; Double-Blind Method; Female; Humans; Hypertension; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Secondary Prevention; Thromboembolism | 2021 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Thromboembolism; Warfarin | 2018 |
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).
Topics: Aged, 80 and over; Aortic Valve Stenosis; Clopidogrel; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; Humans; Incidence; Male; North America; Postoperative Complications; Preoperative Care; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Assessment; Risk Factors; Thromboembolism; Time Factors; Transcatheter Aortic Valve Replacement | 2019 |
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Assessment; Stroke; Thromboembolism; Ticagrelor; Warfarin | 2019 |
Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE Trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Carotid Artery, Common; Clopidogrel; Embolic Protection Devices; Female; Fibrinolytic Agents; Heparin; Humans; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Pulmonary Embolism; Stroke; Thromboembolism; Ultrasonography, Interventional | 2019 |
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Female; Heart Failure; Humans; Irbesartan; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Tetrazoles; Thromboembolism; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left | 2015 |
Secondary prevention of cardiogenic arterial thromboembolism in the cat: The double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT).
Topics: Animals; Aspirin; Cat Diseases; Cats; Clopidogrel; Double-Blind Method; Male; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine | 2015 |
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Topics: Administration, Oral; Aortic Valve Stenosis; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Incidence; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prospective Studies; Survival Rate; Thromboembolism; Ticlopidine; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2016 |
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes.
Topics: Aged; Antineoplastic Agents, Phytogenic; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Europe; Female; Follow-Up Studies; Heparin; Hospital Mortality; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; New South Wales; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Sex Distribution; Sex Factors; ST Elevation Myocardial Infarction; Survival Rate; Thromboembolism; Ticlopidine; Time Factors; United States | 2016 |
Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Severity of Illness Index; Survival Analysis; Thiophenes; Thromboembolism; Ticlopidine; Treatment Outcome | 2009 |
Antiplatelet therapy for prevention of thromboembolic complications associated with coil embolization of unruptured cerebral aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cerebral Angiography; Clopidogrel; Embolization, Therapeutic; Female; Humans; Incidence; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Retrospective Studies; Thromboembolism; Ticlopidine; Treatment Outcome; Young Adult | 2012 |
Prophylactic use of clopidogrel in paediatric cardiac patients.
Topics: Aspirin; Child; Child, Preschool; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Defects, Congenital; Humans; Infant; Male; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thromboembolism; Ticlopidine | 2012 |
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study pr
Topics: Aspirin; Clinical Protocols; Clopidogrel; Coronary Artery Bypass; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Thrombelastography; Thromboembolism; Thrombophilia; Ticlopidine | 2012 |
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Risk Assessment; Severity of Illness Index; Stroke; Thromboembolism; Ticlopidine | 2013 |
Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA).
Topics: Administration, Oral; Adult; Aged; Aortic Valve; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Phenprocoumon; Pilot Projects; Thromboembolism; Ticlopidine; Treatment Outcome | 2003 |
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Bleeding Time; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Electric Countershock; Female; Humans; International Normalized Ratio; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Thromboembolism; Thromboxane B2; Ticlopidine; Warfarin | 2004 |
Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biocompatible Materials; Carbon; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Coronary Restenosis; Equipment Design; Female; Heparin; Humans; Male; Materials Testing; Middle Aged; Prospective Studies; Recurrence; Stainless Steel; Stents; Thromboembolism; Thrombophilia; Ticlopidine; Time Factors; Treatment Outcome; Venous Thrombosis | 2005 |
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.
Topics: Aged; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thromboembolism; Thrombosis; Ticlopidine | 2007 |
Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Coronary Artery Bypass, Off-Pump; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombelastography; Thromboembolism; Thrombophilia; Ticlopidine | 2007 |
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Treatment Outcome | 2007 |
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Chromium Alloys; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Risk; Thromboembolism; Ticlopidine; Time Factors | 2008 |
93 other study(ies) available for clopidogrel and Thromboembolism
Article | Year |
---|---|
Ticagrelor versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.
Topics: Aspirin; Clopidogrel; Embolization, Therapeutic; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thromboembolism; Ticagrelor; Treatment Outcome | 2022 |
Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy.
Topics: Aortic Aneurysm, Abdominal; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Endovascular Procedures; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Treatment Outcome | 2022 |
Risk of Postcolonoscopy Thromboembolic Events: A Real-World Cohort Study.
Topics: Anticoagulants; Clopidogrel; Cohort Studies; Colonoscopy; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; Warfarin | 2023 |
A rare cause of abdominal pain managed unconventionally: acute renal infarction caused by atrial fibrillation: a case report.
Topics: Abdominal Pain; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Diltiazem; Humans; Infarction; Male; Nitroglycerin; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin | 2022 |
Tailored antiplatelet therapy in stent assisted coiling for unruptured aneurysms: a nationwide registry study.
Topics: Clopidogrel; Embolization, Therapeutic; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Stents; Thromboembolism; Treatment Outcome | 2023 |
Ticagrelor versus clopidogrel dual antiplatelet therapy for unruptured intracranial aneurysms treated with flowdiverter.
Topics: Aspirin; Clopidogrel; Hemorrhage; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Ticagrelor; Treatment Outcome | 2023 |
Natural history of antiplatelet nonresponders undergoing carotid artery stenting.
Topics: Carotid Arteries; Carotid Stenosis; Clopidogrel; Humans; Prospective Studies; Stents; Thromboembolism; Ticlopidine | 2023 |
[Comparison of Various Regimens of Antithrombotic Therapy in Patients With Valvular Heart Disease and Coronary Artery Disease After Surgical and Interventional Interventions].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Female; Fibrinolytic Agents; Heart Valve Diseases; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thromboembolism; Treatment Outcome | 2023 |
Early Discontinuation of P2Y
Topics: Age Factors; Aged; Aged, 80 and over; Clopidogrel; Cohort Studies; Drug Prescriptions; Female; Hemorrhage; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Retreatment; Retrospective Studies; Stroke; Thromboembolism; Wales | 2019 |
Preoperative Light Transmission Aggregometry Values Predict for Thromboembolic Complications After Stent-Assisted Coil Embolization.
Topics: Aspirin; Clopidogrel; Embolization, Therapeutic; Endovascular Procedures; Female; Hematoma; Hemorrhage; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Retrospective Studies; Risk Assessment; Stents; Thromboembolism | 2020 |
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percut
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Thromboembolism; Ticagrelor; Treatment Outcome; Warfarin | 2020 |
Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping.
Topics: Adult; Aged; Blood Platelets; Carotid Arteries; Clopidogrel; Dose-Response Relationship, Drug; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Thrombelastography; Thromboembolism; Thrombosis | 2020 |
Failure of platelet function analyser 200 to demonstrate clinical clopidogrel resistance in a patient undergoing intracranial vascular stenting.
Topics: Aged; Aspirin; Clopidogrel; Diagnosis, Differential; Drug Resistance; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Preoperative Care; Stents; Stroke; Thromboembolism; Treatment Outcome; Withholding Treatment | 2020 |
Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Retrospective Studies; Thromboembolism; Ticagrelor; Treatment Outcome; United States | 2020 |
Differences in thromboembolism after stent-assisted coiling for unruptured aneurysms between aspirin plus clopidogrel and ticagrelor.
Topics: Adult; Aged; Aspirin; Clopidogrel; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thromboembolism; Ticagrelor | 2020 |
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel.
Topics: Administration, Oral; Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Thromboembolism; Ticlopidine; Warfarin | 2021 |
Clopidogrel response predicts thromboembolic events associated with coil embolization of unruptured intracranial aneurysms: A prospective cohort study.
Topics: Aged; Blood Vessel Prosthesis; Clopidogrel; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Thromboembolism | 2021 |
The inhibition rate estimated using VerifyNow can help to predict the thromboembolic risk of coil embolization for unruptured intracranial aneurysms.
Topics: Clopidogrel; Embolization, Therapeutic; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Treatment Outcome | 2022 |
Self-expandable metal stents for the extraction of common bile duct stones in patients receiving dual antiplatelet agents: a pilot study.
Topics: Aged; Aged, 80 and over; Aspirin; Cholangiopancreatography, Endoscopic Retrograde; Clopidogrel; Common Bile Duct; Drug Therapy, Combination; Female; Gallstones; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Retrospective Studies; Self Expandable Metallic Stents; Sphincterotomy, Endoscopic; Thromboembolism; Treatment Outcome | 2018 |
Thromboembolism after WATCHMAN
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Resistance; Drug Substitution; Echocardiography, Transesophageal; Female; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome; Warfarin | 2018 |
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures.
Topics: Biological Availability; Cerebrovascular Disorders; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endovascular Procedures; Heparin; Humans; Intracranial Aneurysm; Intraoperative Complications; Metabolic Clearance Rate; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Thromboembolism | 2018 |
Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Time Factors; Warfarin | 2018 |
Antiplatelet Premedication for Stent-Assisted Coil Embolization of Intracranial Aneurysms: Low-Dose Prasugrel vs Clopidogrel.
Topics: Adult; Aged; Clopidogrel; Embolization, Therapeutic; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Premedication; Retrospective Studies; Risk Factors; Stents; Thromboembolism | 2018 |
Defining a Clopidogrel Response Cut-Off Value Using Light Transmission Aggregometry Before Pipeline Embolization of Unruptured Intracranial Aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Dose-Response Relationship, Drug; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Retrospective Studies; Risk; Stents; Thromboembolism; Thrombophilia; Ticlopidine; Treatment Outcome | 2018 |
Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Septal Occluder Device; Thromboembolism; Time Factors; Treatment Outcome | 2019 |
Impact of different dosing regimens of clopidogrel on systemic oxidative stress in patients undergoing elective percutaneous coronary intervention.
Topics: Aged; Clopidogrel; Drug Administration Schedule; Female; Free Radicals; Humans; Male; Middle Aged; Oxidative Stress; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Thromboembolism | 2018 |
Low-Dose Prasugrel vs Clopidogrel-Based Tailored Premedication for Endovascular Treatment of Cerebral Aneurysms.
Topics: Aged; Clopidogrel; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Premedication; Retrospective Studies; Thromboembolism | 2019 |
Thromboembolic Events with Enterprise Versus Pipeline: Porcine In Vivo Experiment.
Topics: Angiography, Digital Subtraction; Animals; Brain Ischemia; Carotid Artery, Common; Clopidogrel; Disease Models, Animal; Embolization, Therapeutic; Feasibility Studies; Graft Occlusion, Vascular; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Failure; Stents; Sus scrofa; Swine; Thromboembolism | 2019 |
Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention.
Topics: Aged; Clopidogrel; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Prasugrel Hydrochloride; Republic of Korea; Thromboembolism; Ticagrelor | 2019 |
Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet Therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Thromboembolism | 2019 |
Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials.
Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Thromboembolism | 2019 |
[Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)].
Topics: Adenosine; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Fibrinolytic Agents; Guideline Adherence; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine; Treatment Outcome | 2013 |
Effect of antiplatelet therapy on thromboembolism after flow diversion with the pipeline embolization device.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Heparin; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Stents; Thromboembolism; Ticlopidine; Treatment Outcome; Young Adult | 2013 |
Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms.
Topics: Adult; Aged; Blood Vessel Prosthesis; Clopidogrel; Diffusion Magnetic Resonance Imaging; Drug Resistance; Embolization, Therapeutic; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine | 2014 |
[New aspects of stroke medicine].
Topics: Anticoagulants; Clopidogrel; Fibrinolytic Agents; Humans; Intermittent Pneumatic Compression Devices; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Thromboembolism; Ticlopidine; Tissue Plasminogen Activator | 2014 |
Heparin resistance and coagulation activation rebound effect after anticoagulant withdrawal: beneficiary effect of adjuvant antiplatelet therapy.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Coagulation; Case-Control Studies; Clopidogrel; Drug Resistance; Enoxaparin; Female; France; Heparin; Humans; Male; Middle Aged; Thromboembolism; Ticlopidine | 2016 |
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Smoking; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2015 |
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Elective Surgical Procedures; Enoxaparin; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Prostate; Prostatic Hyperplasia; Retrospective Studies; Thromboembolism; Ticlopidine; Transurethral Resection of Prostate; Victoria; Warfarin; Withholding Treatment | 2015 |
Ventriculostomy-Related Hemorrhage After Treatment of Acutely Ruptured Aneurysms: The Influence of Anticoagulation and Antiplatelet Treatment.
Topics: Acute Disease; Adult; Aged; Aneurysm, Ruptured; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Heparin, Low-Molecular-Weight; Humans; Hydrocephalus; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine; Ventriculostomy | 2015 |
Accumetrics-based clopidogrel dosing in endovascular neurosurgery.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Endovascular Procedures; Female; Humans; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Thromboembolism; Ticlopidine; Treatment Outcome | 2015 |
Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement.
Topics: Adult; Aged; Aspirin; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Stents; Thromboembolism; Ticlopidine | 2016 |
Platelet reactivity in patients undergoing transcatheter aortic valve implantation.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Transcatheter Aortic Valve Replacement; Warfarin | 2016 |
P2Y
Topics: Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Sensitivity and Specificity; Thromboembolism; Ticlopidine; Treatment Outcome | 2017 |
Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
Topics: Administration, Oral; Animals; Aspirin; Bioprosthesis; Clopidogrel; Dalteparin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Valve Prosthesis Implantation; Injections, Subcutaneous; Postoperative Care; Postoperative Complications; Random Allocation; Risk Factors; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Swine; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Time Factors | 2008 |
Plateletworks: a screening assay for clopidogrel therapy monitoring in healthy cats.
Topics: Animals; Blood Platelets; Cardiomyopathies; Cat Diseases; Cats; Clopidogrel; Female; Male; Monitoring, Physiologic; Orchiectomy; Ovariectomy; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Thromboembolism; Ticlopidine | 2009 |
Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Chronic Disease; Clopidogrel; Coronary Disease; Disease-Free Survival; Drug Therapy, Combination; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2009 |
[Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopidogrel; Contraindications; Drug Therapy, Combination; Female; Gastrostomy; Heparin, Low-Molecular-Weight; Humans; Infant; Male; Middle Aged; Multivariate Analysis; Peritonitis; Pilot Projects; Postoperative Complications; Postoperative Hemorrhage; Prognosis; Prospective Studies; Risk Factors; Surgical Wound Infection; Thromboembolism; Ticlopidine | 2010 |
Aortic thromboembolism successfully treated with anticoagulation and antiplatelet therapy.
Topics: Anticoagulants; Aorta, Thoracic; Arm; Clopidogrel; Coronary Artery Disease; Echocardiography, Transesophageal; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Warfarin | 2009 |
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk; Stents; Stroke; Thromboembolism; Thrombosis; Ticlopidine; Warfarin | 2009 |
Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses.
Topics: Aged; Aortic Valve; Aspirin; Blood Platelets; Clopidogrel; Drug Combinations; Female; Follow-Up Studies; Heart Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Puerto Rico; Thromboembolism; Ticlopidine; United States | 2009 |
Triple therapy: the future or from the past?
Topics: Administration, Oral; Anticoagulants; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prognosis; Risk Factors; Stents; Thromboembolism; Ticlopidine | 2010 |
Triple therapy: triple safety or triple danger?
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug Tolerance; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Stents; Thromboembolism; Ticlopidine; Treatment Outcome | 2010 |
Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Prospective Studies; Risk Factors; Stroke; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2010 |
Letter by Doraiswamy regarding article, "Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring
Topics: Anticoagulants; Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Double-Blind Method; Drug Resistance; Elective Surgical Procedures; Hemorrhage; Heparin; Humans; Myocardial Revascularization; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Research Design; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine | 2010 |
[Comment about patients with dual antiplatelet therapy].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Contraindications; Drug Therapy, Combination; Elective Surgical Procedures; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Preoperative Care; Thromboembolism; Ticlopidine | 2010 |
[Balancing act in antithrombotic therapy. Between hemorrhage and embolism].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Phenprocoumon; Proton Pump Inhibitors; Stents; Thromboembolism; Ticlopidine | 2010 |
Gastric acid-reducing medications and clopidogrel: what are the latest FDA recommendations?
Topics: Anticoagulants; Clopidogrel; Drug Interactions; Endoscopy, Gastrointestinal; Female; Humans; Male; Omeprazole; Proton Pump Inhibitors; Safety Management; Thromboembolism; Ticlopidine; United States; United States Food and Drug Administration | 2010 |
Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events: post-operative transcranial Doppler monitoring is now unnecessary.
Topics: Aged; Angioscopy; Anticoagulants; Aspirin; Clopidogrel; Dextrans; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Fibrinolytic Agents; Humans; Male; Medical Audit; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Retrospective Studies; Thromboembolism; Ticlopidine; Ultrasonography, Doppler, Transcranial | 2010 |
Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
Topics: Aspirin; Cardiac Catheterization; Clopidogrel; Echocardiography, Transesophageal; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Septal Occluder Device; Stroke; Surveys and Questionnaires; Thromboembolism; Ticlopidine | 2011 |
Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".
Topics: Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Therapy, Combination; Eye Hemorrhage; Female; Humans; Intraoperative Complications; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Prothrombin Time; Risk Assessment; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Putting genomics into practice.
Topics: Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Male; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thromboembolism; Ticlopidine | 2011 |
Atrial fibrillation treatment update.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Heart Rate; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Thromboembolism; Ticlopidine | 2011 |
Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approach.
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Evidence-Based Medicine; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Risk Assessment; Surgical Procedures, Operative; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Warfarin | 2011 |
[Perioperative anti-platelet therapy management--protocol suggestion].
Topics: Aspirin; Blood Loss, Surgical; Clinical Protocols; Clopidogrel; Drug Therapy, Combination; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Risk Factors; Thromboembolism; Ticlopidine | 2011 |
[Pharmacoeconomic analysis of dabigatran etexilate effectiveness in patients with nonvalvular atrial fibrillation].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Blood Coagulation; Blood Coagulation Tests; Clopidogrel; Costs and Cost Analysis; Dabigatran; Humans; Insurance, Pharmaceutical Services; Models, Statistical; Outcome and Process Assessment, Health Care; Pyridines; Russia; Thromboembolism; Ticlopidine | 2012 |
[Resistance to antiplatelet agents assessed by a point-of-care platelet function test and thromboembolic adverse events in neurointervention].
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Tetrazoles; Thromboembolism; Ticlopidine | 2012 |
Long-term successful percutaneous coronary intervention in factor VII deficiency.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Diabetes Mellitus, Type 2; Factor VII Deficiency; Follow-Up Studies; Humans; Male; Middle Aged; Obesity, Morbid; Platelet Aggregation Inhibitors; Radiography; Risk Assessment; Stents; Thromboembolism; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting.
Topics: Aged; Aspirin; Blood Platelets; Cerebral Arteries; Clopidogrel; Dose-Response Relationship, Drug; Drug Resistance; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thromboembolism; Ticlopidine | 2013 |
Platelet-function testing in patients undergoing neurovascular procedures: caught between a rock and a hard place.
Topics: Cerebral Hemorrhage; Clopidogrel; Drug Resistance; Endovascular Procedures; Female; Humans; Male; Platelet Aggregation Inhibitors; Stents; Thromboembolism; Ticlopidine | 2013 |
[Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clopidogrel; Dabigatran; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2012 |
Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Models, Cardiovascular; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptor, PAR-1; Receptors, Purinergic P2Y12; Thrombin; Thromboembolism; Ticlopidine; Translational Research, Biomedical | 2013 |
New antiplatelet agents and prosthetic heart valves.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Clopidogrel; Female; Heart Valve Prosthesis Implantation; Humans; Immunoglobulin Fab Fragments; Infant; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Thromboembolism; Ticlopidine | 2002 |
In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability.
Topics: Adenosine Monophosphate; Administration, Oral; Animals; Blood Platelets; Calcium; Clopidogrel; Female; Male; Membrane Proteins; Platelet Activation; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Rabbits; Receptors, Purinergic P2Y12; Thrombin; Thromboembolism; Ticlopidine | 2003 |
[Anticoagulation and antiaggregation in cardiac patients].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Humans; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Ticlopidine | 2003 |
[Must platelet aggregation inhibitors be discontinued before surgery?].
Topics: Angiography; Aspirin; Blood Loss, Surgical; Clopidogrel; Humans; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Risk Factors; Thromboembolism; Ticlopidine | 2004 |
Effect of clopidogrel on tissue-plasminogen activator-induced in vitro thrombolysis of feline whole blood thrombi.
Topics: Animals; Cat Diseases; Cats; Clopidogrel; Fibrinolytic Agents; In Vitro Techniques; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Time Factors; Tissue Plasminogen Activator | 2004 |
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Administration, Oral; Aspirin; Clopidogrel; Coronary Thrombosis; Evidence-Based Medicine; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism; Ticlopidine; Treatment Outcome | 2004 |
Antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine | 2004 |
[Two approaches to correction of disturbed hemostasis in patients with mechanical artificial heart valves at the long-term follow-up].
Topics: Aspirin; Blood Coagulation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Nadroparin; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Treatment Outcome | 2004 |
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clopidogrel; Drug Therapy, Combination; Feasibility Studies; Humans; Pilot Projects; Platelet Aggregation Inhibitors; Research Design; Thromboembolism; Ticlopidine; Warfarin | 2005 |
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice.
Topics: Animals; Aspirin; Blood Coagulation Tests; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Hemorrhage; Male; Mice; Mice, Inbred Strains; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Survival Rate; Thromboembolism; Ticlopidine; Tunica Intima | 2005 |
Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
Topics: Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Thromboembolism; Ticlopidine | 2006 |
[Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment].
Topics: Administration, Oral; Age Factors; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Germany; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Registries; Risk Factors; Thromboembolism; Ticlopidine; Vitamin K | 2006 |
Antithrombotic therapy in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Clopidogrel; Drug Interactions; Heart Failure; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism; Ticlopidine; Warfarin | 2006 |
Impact of PlA polymorphism of platelet GP IIb/IIIa receptors on clinical course during long-term LVAD support is independent of type of LVAD.
Topics: Anticoagulants; Antigens, Human Platelet; Aspirin; Clopidogrel; Equipment Design; Genetic Predisposition to Disease; Genotype; Heart-Assist Devices; Hemorrhagic Disorders; Humans; Incidence; Integrin beta3; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Postoperative Complications; Thromboembolism; Thrombophilia; Ticlopidine | 2006 |
Clopidogrel resistance: role of body mass and concomitant medications.
Topics: Benzodiazepines; Body Mass Index; Clopidogrel; Drug Interactions; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thromboembolism; Ticlopidine | 2007 |
Update on the use of antiplatelet agents in secondary stroke prevention.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine | 2007 |
[Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Drug Therapy, Combination; Follow-Up Studies; Hemorrhage; Humans; Intracranial Embolism; Irbesartan; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tetrazoles; Thromboembolism; Ticlopidine | 2007 |
[Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Recurrence; Stroke; Thromboembolism; Ticlopidine | 2007 |
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clopidogrel; Combined Modality Therapy; Dipyridamole; Early Ambulation; Enoxaparin; Female; Fibrinolytic Agents; Hematologic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Thromboembolism; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |
Outcomes associated with combined antiplatelet and anticoagulant therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2008 |
[Thrombosis prophylaxis after stroke].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clopidogrel; Heparin; Humans; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Thromboembolism; Thrombosis; Ticlopidine | 1998 |